Vivos Therapeutics, Inc. Adjustment of Warrants Granted for Services
Vivos Therapeutics, Inc. (VVOS) reported Adjustment of Warrants Granted for Services of $31.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:AdjustmentOfWarrantsGrantedForServices · last filed 2026-04-15
- Vivos Therapeutics, Inc. adjustment of warrants granted for services for the quarter ending 2024-12-31 was $5.00K, a 94.19% decline year-over-year.
- Vivos Therapeutics, Inc. adjustment of warrants granted for services for the quarter ending 2024-09-30 was $6.00K.
- Vivos Therapeutics, Inc. adjustment of warrants granted for services for the quarter ending 2024-06-30 was $14.00K, a 92.35% decline year-over-year.
- Vivos Therapeutics, Inc. adjustment of warrants granted for services for the quarter ending 2024-03-31 was $6.00K, a 99.04% decline year-over-year.
- Vivos Therapeutics, Inc. adjustment of warrants granted for services for fiscal 2024 was $31.00K, a 95.79% decline from fiscal 2023.
- Vivos Therapeutics, Inc. adjustment of warrants granted for services for fiscal 2023 was $737.00K, a 3.66% increase from fiscal 2022.
- Vivos Therapeutics, Inc. adjustment of warrants granted for services for fiscal 2022 was $711.00K, a 206.47% increase from fiscal 2021.
- Vivos Therapeutics, Inc. adjustment of warrants granted for services for fiscal 2021 was $232.00K.
| Period end | Adjustment of Warrants Granted for Services 0 month | Adjustment of Warrants Granted for Services 3 month | Adjustment of Warrants Granted for Services 3 month as first filed | Adjustment of Warrants Granted for Services 6 month | Adjustment of Warrants Granted for Services 6 month as first filed | Adjustment of Warrants Granted for Services 9 month | Adjustment of Warrants Granted for Services 9 month as first filed | Adjustment of Warrants Granted for Services 12 month |
|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $11.00K derived: sum of 2 quarters · filed 2026-04-15 | $25.00K derived: sum of 3 quarters · filed 2026-04-15 | $31.00K 10-K · filed 2026-04-15 | ||||
| 2024-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $20.00K derived: sum of 2 quarters · filed 2025-11-19 | $26.00K 10-Q · filed 2025-11-19 | $112.00K derived: sum of 4 quarters · filed 2025-11-19 | ||||
| 2024-06-30 | $14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | $20.00K 10-Q · filed 2025-08-19 | $106.00K derived: sum of 3 quarters · filed 2025-08-19 | -$51.00K derived: sum of 4 quarters · filed 2025-08-19 | ||||
| 2024-03-31 | $6.00K 10-Q · filed 2025-05-15 | $92.00K derived: sum of 2 quarters · filed 2025-05-15 | -$65.00K derived: sum of 3 quarters · filed 2025-05-15 | $118.00K derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | $86.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$71.00K derived: sum of 2 quarters · filed 2025-03-31 | $112.00K derived: sum of 3 quarters · filed 2025-03-31 | $737.00K 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | -$157.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $26.00K derived: sum of 2 quarters · filed 2024-11-14 | $651.00K 10-Q · filed 2024-11-14 | $910.00K derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $183.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $808.00K 10-Q · filed 2024-08-14 | $1.07M derived: sum of 3 quarters · filed 2024-08-14 | $1.17M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $625.00K 10-Q · filed 2024-05-14 | $884.00K derived: sum of 2 quarters · filed 2024-07-30 | $984.00K derived: sum of 3 quarters · filed 2024-07-30 | $1.11M derived: sum of 4 quarters · filed 2024-07-30 | ||||
| 2022-12-31 | $259.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-07-30 | $359.00K derived: sum of 2 quarters · filed 2024-07-30 | $489.00K derived: sum of 3 quarters · filed 2024-07-30 | $711.00K 10-K/A · filed 2024-07-30 | ||||
| 2022-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $230.00K derived: sum of 2 quarters · filed 2023-11-14 | $452.00K 10-Q · filed 2023-11-14 | $452.00K derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $130.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-16 | $352.00K 10-Q · filed 2023-08-16 | $352.00K derived: sum of 3 quarters · filed 2023-08-16 | $352.00K derived: sum of 4 quarters · filed 2023-08-16 | ||||
| 2022-03-31 | $222.00K 10-Q · filed 2023-06-08 | $222.00K derived: sum of 2 quarters · filed 2023-06-08 | $222.00K derived: sum of 3 quarters · filed 2023-06-08 | $222.00K derived: sum of 4 quarters · filed 2023-06-08 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $0.00 derived: sum of 2 quarters · filed 2023-03-30 | $0.00 derived: sum of 3 quarters · filed 2023-03-30 | $232.00K 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-12-20 | $0.00 derived: sum of 2 quarters · filed 2022-12-20 | $232.00K 10-Q · filed 2022-12-20 | $231.72K 10-Q · filed 2021-11-15 | ||||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2022-12-20 | $232.00K 10-Q · filed 2022-12-20 | $231.72K 10-Q · filed 2021-08-12 | |||||
| 2021-03-31 | $232.00K 10-Q/A · filed 2022-11-25 | $231.72K 10-Q · filed 2021-05-17 | ||||||
| 2021-03-29 | $25.00K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |